Search results
Results from the WOW.Com Content Network
The first-ever pill for postpartum depression, zuranolone, was approved last year. Doctors are starting to prescribe it to patients, with positive results.
The day after the trial participants completed a 14-day treatment course of zuranolone, the researchers found that 57% reported a 50% or higher improvement in their depressive symptoms, compared ...
The FDA approve a new pill for postpartum depression, zuranolone aka zurzuvae. The pill got rid of PPD symptoms for a struggling new mom in a clinical trial.
Zuranolone, sold under the brand name Zurzuvae, is a medication used for the treatment of postpartum depression. [5] [6] It is taken by mouth.[5]The most common side effects include drowsiness, dizziness, diarrhea, fatigue, nasopharyngitis, and urinary tract infection.
In August the Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication to treat postpartum depression.The approval is a big step for women with the condition, which ...
Allopregnanolone is a naturally occurring neurosteroid which is made in the body from the hormone progesterone. [10] [11] As a medication, allopregnanolone is referred to as brexanolone, sold under the brand name Zulresso, [6] [12] and used to treat postpartum depression.
Postpartum depression (PPD), also called perinatal depression, is a mood disorder which may be experienced by pregnant or postpartum individuals. [3] Symptoms include extreme sadness, low energy, anxiety, crying episodes, irritability, and changes in sleeping or eating patterns. [1] PPD can also negatively affect the newborn child. [4] [2]
The FDA is about to decide whether to approve the first-ever pill for postpartum depression. The medication could also get approved for clinical depression.